Abstract: A computer architecture for graph-traversal provides a processor for bottom-up sequencing through the graph data according to vertex degree. This ordered sequencing reduces redundant edge checks. In one embodiment, vertex adjacency data describing the graph may be allocated among different memory structures in the memory hierarchy to provide faster access to vertex data associated with vertices of higher degree reducing data access time. The adjacency data also may be coded to provide higher compression in memory of vertex data having high vertex degree.

Abstract: A phase shifter includes a first dielectric layer, a switch mounted to the first dielectric layer, a conductive layer mounted to the first dielectric layer, a second dielectric layer mounted to the conductive layer, a conducting pattern layer mounted to the second dielectric layer, and a plurality of vias. The switch is switchable between a first conducting position and a second conducting position. Each via is connected between a first or a second throw arm of the switch and a conductor of the conducting pattern layer. When an electromagnetic wave incident on the phase shifter is reflected, an electric polarization of the reflected electromagnetic wave is rotated by ±90 degrees compared to an electric polarization of the incident electromagnetic wave based on a conducting position of the switch. The phase shifter can be used as one-bit spatial phase shifter to provide either 0° or 180° phase shift over wide bandwidths.

Abstract: The present invention provides synthetic peptide compounds and uses thereof for therapy and diagnostics of complement-mediated diseases, such as inflammatory diseases, autoimmune diseases, and microbial and bacterial infections; and non-complement-mediated diseases, such cystic fibrosis and various acute diseases. The invention is directed to modifications of a synthetic peptide of 15 amino acids from the Polar Assortant (PA) peptide, which is a scrambled peptide derived from human Astrovirus protein. In some embodiments, the invention is directed to peptide compounds that are peptide mimetics, peptide analogs and/or synthetic derivatives of PA (e.g., sarcosine derivatives) having, for example, internal peptide substitutions, and modifications, including PEGylation at the N-terminus and C-terminus. The invention further provides methods of selecting at least one synthetic peptide for treating various conditions.

Abstract: A manipulator comprises a first member, a second member that supports the first member such that the first member can rotate about a first rotation axis, a driven portion connected to the first member, which moves on a circumference with respect to the first rotation axis as a center in accordance with a rotation operation of the first member, a flexible member that provides, by a reciprocating operation, a force to drive the driven portion, and a change unit including an arc guide surface, which changes a path of the flexible member in accordance with the rotation operation of the first member. The arc guide surface is arranged to maintain a path length of the flexible member in the reciprocating operation during the rotation operation of the first member.

Abstract: Provided is a method for automatically generating a search heuristic that is optimal for a test subject program and a method of concolic testing that uses a parameterized search heuristic to yield a consistent test performance for any program.

Abstract: The present invention addresses the problem of providing a polycyclic aromatic compound which has improved solubility in solvents, film formability, wet coatability and in-plane orientation. The above-described problem is solved by a composition for forming a light emitting layer, which contains, as a first component, at least one compound selected from the group consisting of compounds represented by general formula (A-1) and compounds represented by general formula (A-2), as a second component, at least one compound that has a triplet energy (ET) of 1.8-3.0 eV, and as a third component, at least one organic solvent. In the formulae, R represents a hydrogen atom, an aryl group, a heteroaryl group, a diarylamino group, a diheteroarylamino group or an aryl heteroarylamino group.

Abstract: The present disclosure discloses a strain sensor and a method of fabricating the same. The strain sensor according to an embodiment of the present disclosure includes an X-axis sensor formed on a flexible insulating substrate and responsible for sensing X-axis strain; a Y-axis sensor formed on the flexible insulating substrate to be orthogonal to the X-axis sensor and responsible for sensing Y-axis strain; a metal electrode formed on a region of the flexible insulating substrate where the X-axis sensor and the Y-axis sensor are not formed; and an encapsulation layer formed on the X-axis sensor, the Y-axis sensor, and the metal electrode. In this case, the X-axis sensor and the Y-axis sensor have a metal-insulator heterostructure.

Abstract: A method of obtaining an in-memory vector-based dot product is disclosed, which includes providing a matrix of memory cells having M rows, each memory cell in each row holding a value and having dedicated read transistors T1 and T2, where T1 is controlled by the value held in the associated memory cell and T2 is controlled by a row-dedicated source (vin) for each row, the combination of the T1 and T2 transistors for each cell selectively (i) couple a reference voltage with a column-dedicated read bit line (RBL) for each column for an in-memory vector-based dot product operation or (ii) couple ground with the column-dedicated read bit line (RBL) for each column for a memory read operation, where total resistance of the read transistors (R) for each cell in each row is based on Rmax/2(M-1), . . . Rmax, where Rmax is the resistance of the least significant cell in each row.

Abstract: Provided is a resist compound, a method for forming a pattern using the same, and a method for manufacturing a semiconductor device. According to the present disclosure, the compound may be represented by Formula 1.

Abstract: This document relates to adenovirus vectors and methods and materials related to using adenovirus vectors. For example, viruses, nucleic acid molecules encoding viruses, cell lines containing viral vectors, and methods for using viruses to deliver nucleic acid to cells in vitro or in vivo are provided. Methods and materials for using adenovirus vectors to induce immune responses and to treat cancer also are provided.

Abstract: A semiconductor device includes a signal input circuit configured to select one of the plurality of differential sensor signals according to a channel selection signal; an amplifier circuit configured to amplify an output of the signal input circuit; and an analog-to-digital converter (ADC) configured to convert an output of the amplifier circuit into a digital value, wherein each of the plurality of sensor signals is a differential signals and the signal input circuit changes polarity of an output signal thereof according to a first chopping signal, and wherein the ADC includes a delta-sigma modulator configured to generate a bit stream from an output of the amplifier circuit; an output chopping circuit configured to adjust phase of the bit stream according to the first chopping signal; and a filter configured to filter an output of the output chopping circuit and to output the digital value.

Abstract: This document describes methods and devices for using electrical stimulation to control physiological functions such as breathing of patients suffering from respiratory impairment. For example, this document describes methods and devices for generating effective breaths and airway protection by determining times and depths of breaths in accordance with physiological demand, and coordinating respiratory muscle stimulation with the breaths to control breathing.

Abstract: Disclosed herein is a platform and method to quantify spatiotemporal tissue swelling during biologics injection, and to predict associated increase in the mechanical stress and interstitial fluid pressure (IFP) of tissues. Accurate measure and estimation of tissue swelling, thus, can be quantitative and predictive indicator of the IPD.

Abstract: An atmospheric pressure plasma device is disclosed. The atmospheric pressure plasma device includes a conductive tube connected to a power device, an electrode formed as a plate and receiving power supplied from the conductive tube and a dielectric configured to control discharge instability by being formed to surround a side surface of the electrode.

Abstract: A method for encoding image signal, according to the present invention, can: encode a partial block coefficient flag indicating whether a coefficient of a current partial block is a non-zero coefficient; encode a first flag indicating whether an absolute value of the coefficient is greater than 1, encode a second flag indicating whether the absolute value of the coefficient is greater than 2; encode the residual coefficients, which have not been encoded, on the basis of the first flag or the second flag in the current partial block; and encode a code for the coefficient of the current partial block.

Abstract: Disclosed are a method and an apparatus for verifying times and locations of image data of cameras for vehicles. The method for verifying times and locations of image data of cameras for vehicles includes anonymously receiving digests including locations and times of data created by cameras for a plurality of vehicles, respectively, forming a mesh structure by bi-directionally connecting the cameras for the plurality of vehicles to cameras for adjacent vehicles, based on a relationship between the received digests, and if the mesh structure is formed, verifying times and locations for the digests constituting the mesh structure based on the formed mesh structure.

Abstract: A method of treating a malignant solid tumor in a subject is disclosed herein. The method includes the steps of administering to the subject an immunomodulatory dose of a radiohalogenated compound that is differentially taken up by and retained within malignant solid tumor tissue, and performing in situ tumor vaccination in the subject by intratumorally injecting into (or treating via a separate method) at least one of the malignant solid tumors a composition that includes one or more agents capable of stimulating specific immune cells within the tumor microenvironment. In certain exemplary embodiments, the radiohalogenated compound has the formula: wherein R1 is a radioactive halogen isotope, n is 18 and R2 is —N+(CH3)3.

Abstract: Wearable systems and associated methods for treatment of a neurocognitive impairment, disease or disorder in patients including a wearable visual field occluder; an attachment system configured for releasably attaching the wearable visual field occluder to th patient during treatment such that, when attached to the patient, the visual field occluder blocks visual feedback of an arm movement of the patient; and an eyewear having at least one lens comprising a prism, wherein the eyewear is configured to be worn by the patient separate and unsupported by the wearable visual field occluder.

Abstract: The present invention relates to antibodies or antibody fragments that bind, neutralize, and/or inhibit Hendra or Nipah virus. The invention provides antibodies or antibody fragments that selectively bind to the F glycoprotein of Hendra or Nipah virus, and pharmaceutical compositions including such antibodies and/or fragments. The invention further provides polynucleotides encoding the antibodies and fragments of the invention and host cells transformed therewith. Additionally, the invention discloses prophylactic, therapeutic, and diagnostic methods employing the antibodies, fragments, polynucleotides, and/or compositions of the invention.

Abstract: Cell-targeted serine protease constructs are provided. Such constructs can be used in methods for targeted cell killing such as for treatment cell of proliferative diseases (e.g., cancer). In some aspects, recombinant serine proteases, such as Granzyme B polypeptides, are provided that exhibit improved stability and cell toxicity. Methods and compositions for treating lapatinib or trastuzumab-resistant cancers are also provided.